(Q51557446)

7 April 2018

title

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. (English)

1 reference

7 April 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

1 reference

2

1 reference

7 April 2018

author name string

S J Winters

1

1 reference

7 April 2018

D S Guzick

3

1 reference

7 April 2018

J Zborowski

4

1 reference

7 April 2018

K P McHugh

5

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

7 April 2018

published in

Fertility and Sterility

1 reference

7 April 2018

volume

73

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

page(s)

724-729

1 reference

7 April 2018

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

The ubiquitous polycystic ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Insulin resistance in nonobese patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Polycystic ovary syndrome, hyperthecosis and the menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Bioavailability of albumin-bound testosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Serum Androstenedione and Testosterone Levels During the Menstrual Cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

The ovarian androgen producing cells: a review of structure/function relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Role of cytochrome P450c17 in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Effect of recombinant activin on androgen synthesis in cultured human thecal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

The Hormonal Activity of the Postmenopausal Ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Hormonal profiles after the menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Reproductive health and polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Case-control study of endogenous steroid hormones and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Risk factors for endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

Evidence for diminished midcycle ovarian androgen production in older reproductive aged women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900641-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(99)00641-X

1 reference

7 April 2018

release_6xvj25a56fgxnabyr6nwdk5g6y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6xvj25a56fgxnabyr6nwdk5g6y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

7 April 2018